Merck & Co. agreed to acquire Cidara Therapeutics Inc., a biotech company developing a flu treatment, as part of its ongoing efforts to make up for the upcoming patent loss of its blockbuster cancer drug Keytruda.
Bloomberg - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Company
Trending
Categories
© Bloombergnews. All rights resereved